Syneos Health is a fully integrated biopharmaceutical solutions organization. The company's core business is built to accelerate customer success by translating clinical, medical affairs, and commercial insights into outcomes. It operates across the biopharmaceutical and oncology sectors.
The organization employs approximately 29,000 people and maintains operations in 110 countries. Its work in oncology is notable: the company has been involved in the development or commercialization of 96% of novel oncology drugs approved by the FDA in recent five-year periods, and 93% of oncology products granted marketing authorization by the EMA in similar periods.
Syneos Health describes its workforce as passionate problem solvers who collaborate to innovate and accelerate. The company's integrated model combines clinical and commercial capabilities to support pharmaceutical development from early stages through market launch.
